Cargando…
Suplatast Tosilate and Eicosapentaenoic Acid as a Possible Strategy for Maintaining Remission in Minimal Change Nephrotic Syndrome: A Case Report
We report a case of a sudden onset of minimal change nephrotic syndrome (MCNS) in a 33-year-old woman with type 1 diabetes mellitus (T1DM), stable microalbuminuria, and chronic thyroiditis. She was successfully treated with intravenous corticosteroids to finally attain a complete remission. Four yea...
Autores principales: | Shichijo, Ayako Y, Iwatani, Hirotsugu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688509/ https://www.ncbi.nlm.nih.gov/pubmed/38034245 http://dx.doi.org/10.7759/cureus.48048 |
Ejemplares similares
-
Case of Eosinophilic Cystitis Treated with Suplatast Tosilate as Maintenance Therapy
por: Yoshino, Tateki, et al.
Publicado: (2012) -
Effectiveness of a combination of cyclosporine A, suplatast tosilate and prednisolone on periodic oscillating hypereosinophilia
por: Imashuku, Shinsaku, et al.
Publicado: (2011) -
Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo.
por: Kurokawa, M, et al.
Publicado: (2001) -
The inhibitory effect of anti-allergic agent suplatast tosilate (IPD-1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice. asakazu@med.showa-u.dc.jp.
por: Asano, K, et al.
Publicado: (2000) -
Dasatinib-Induced Nephrotic Syndrome: A Case Report
por: ElShaer, Ahmed, et al.
Publicado: (2021)